The Flowr (TSXV:FLWR.H) Common Stock : C$284.09 Mil (As of Sep. 2022)

View and export this data going back to 2017. Start your Free Trial

What is The Flowr Common Stock?

The Flowr's quarterly common stock increased from Mar. 2022 (C$282.85 Mil) to Jun. 2022 (C$284.09 Mil) but then stayed the same from Jun. 2022 (C$284.09 Mil) to Sep. 2022 (C$284.09 Mil).

The Flowr's annual common stock increased from Dec. 2019 (C$179.44 Mil) to Dec. 2020 (C$264.58 Mil) and increased from Dec. 2020 (C$264.58 Mil) to Dec. 2021 (C$282.85 Mil).

The Flowr Common Stock Historical Data

The historical data trend for The Flowr's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Flowr Common Stock Chart

The Flowr Annual Data

Trend

Jun17

Jun18

Dec19

Dec20

Dec21

Common Stock

0.21

0.39

179.44

264.58

282.85

The Flowr Quarterly Data
	Sep17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Common Stock	Get a 7-Day Free Trial															282.14	282.85	282.85	284.09	284.09

The Flowr Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

The Flowr (TSXV:FLWR.H) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Flowr Corp (TSXV:FLWR.H) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

9590 McCarthy Road, Kelowna, BC, CAN, V4V 1R2

Website

https://www.flowr.ca

The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.

The Flowr (TSXV:FLWR.H) Headlines

No Headlines